Milestone Pharmaceuticals (MIST) Profit After Tax (2018 - 2022)

Milestone Pharmaceuticals (MIST) has 5 years of Profit After Tax data on file, last reported at -$14.6 million in Q3 2022.

• Quarterly Profit After Tax fell 2.33% year-over-year to -$14.6 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was -$62.3 million (down 79.91% YoY) and the FY2021 annual result came in at -$42.9 million, up 14.24% from the prior year.
• Profit After Tax improved to -$14.6 million in Q3 2022, from -$16.6 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $770000.0 in Q2 2021 to a low of -$18.3 million in Q4 2019.
• A 5-year average of -$11.2 million and a median of -$12.7 million in 2019 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2021 — Profit After Tax soared 105.93% — and 2022, when it sank 2262.08%.
• Tracing MIST's Profit After Tax over 5 years: stood at -$9.7 million in 2018, then sank by 88.21% to -$18.3 million in 2019, then surged by 52.61% to -$8.7 million in 2020, then sank by 94.83% to -$16.9 million in 2021, then grew by 13.79% to -$14.6 million in 2022.
• The last three Profit After Tax figures came in at -$14.6 million (Q3 2022), -$16.6 million (Q2 2022), and -$16.9 million (Q4 2021), per Business Quant data.